Pepcid AC, Acid controller comarketed by Johnson & Johnson and Merck, is a combination of the H2-blocker famotidine (10 mg) with the antacids calcium carbonate (800 mg) and magnesium hydroxide (165 mg). It is administered as chewable tablets and used to treat heartburn.
An equivalent UK product, Pepcidtwo, has identical quantities of active ingredients and is marketed by McNeil Ltd, a Johnson & Johnson company. It is sold in packs of 6 or 12. It is noted that each tablet contains 155 mg sucrose and 62 mg lactose and hence the product is not suitable for people intolerant to those sugars. The same product is also marketed in various European Economic Area countries under the following brands: Pepcid Duo (Finland, Sweden), Pepcidduo (France, Norway), Pepciddual (Germany, Italy), Pepcidtwo (Ireland, United Kingdom).
- Tricia M. Berry, Nursing nonprescription drug handbook
- "LÄKEMEDELSFAKTA : Bipacksedel : Pepcid Duo, tuggtablett" (in Swedish). The Swedish Association of the Pharmaceutical Industry / FASS.se. Retrieved 2007-08-03.
|This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it.|